The Role of Oncolytic Viral Therapy in the Management of Patients With Metastatic Melanoma

The Role of Oncolytic Viral Therapy in the Management of Patients With Metastatic Melanoma

Program Overview

This CME/CE program will delve into the role of oncolytic viral therapy in the treatment and management of the metastatic melanoma patients, highlighting data presented at the Maui and Hawaii Dermatology 2018 annual meetings. The three expert faculty will review the immunotherapy for melanoma, followed by a discussion of recent safety and efficacy trial data for this emerging ...
View Course
Updated Therapeutic Strategies to Improve Outcomes in Patients with Breast Cancer

Updated Therapeutic Strategies to Improve Outcomes in Patients with Breast Cancer

Program Overview

This CME/CNE program will highlight recent advances in the treatment and management of breast cancer, as presented at the 40th Annual San Antonio Breast Cancer Symposium in San Antonio, Texas. Three expert faculty will review the pathophysiology of breast cancer and the rationale for therapeutic choices. An evaluation of recent clinical trial data of current and emerging therapies ...
View Course
Novel Therapeutics in the Treatment and Management of Multiple Myeloma at ASH 2017

Novel Therapeutics in the Treatment and Management of Multiple Myeloma at ASH 2017

Program Overview

This CME/CNE program will discuss recent advances in the treatment and management of multiple myeloma (MM) as presented at the American Society of Hematology 59th Annual Meeting & Exposition in Atlanta, Georgia. The expert faculty panel will provide learners with a scientific update regarding kidney toxicity, fractures, and other skeletal related events as they relate to MM patient ...
View Course
Best Practices to Apply JAK Inhibitors for the Management of Patients With Polycythemia Vera

Best Practices to Apply JAK Inhibitors for the Management of Patients With Polycythemia Vera

Program Overview

This CE program will highlight recent scientific advances in the treatment and management of patients with polycythemia vera (PV) presented at the American Society of Hematology 59th Annual Meeting & Exposition in Atlanta, Georgia. The three expert faculty will review the science and diagnostic criteria of PV, focusing on the treatment of the resistant/intolerant patient population. Recent clinical ...
View Course